Showing results (971-980 of 1,018) with videos related to

Sort By:
Pageof 102
Microbiology Spectrum|July 23, 2025
Analysis of Fc-dependent effector functions of anti-malaria circumsporozoite protein antibodiesErin Stefanutti, Rashmi Ramani, Bradley Whitener, et al.
Oncoimmunology|February 14, 2022
Functional and molecular characterization of PD1<sup>+</sup> tumor-infiltrating lymphocytes from lung cancer patientsJesse J Lipp, Limei Wang, Haitang Yang, et al.
Cell Metabolism|June 12, 2012
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolismArvand Haschemi, Paul Kosma, Lars Gille, et al.
Oncogene|September 2, 2018
mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancerShun-Qing Liang, Elias D Bührer, Sabina Berezowska, et al.
Cell Death Discovery|February 10, 2023
MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesotheliomaHaitang Yang, Yanyun Gao, Duo Xu, et al.
The Journal of Experimental Medicine|April 17, 2013
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2Jonas S Jutzi, Ruzhica Bogeska, Gorica Nikoloski, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 10, 2022
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatmentKatarzyna Furrer, Walter Weder, Eric Innocents Eboulet, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 30, 2018
Outcomes from the Delphi process of the Thoracic Robotic Curriculum Development CommitteeGiulia Veronesi, Patrick Dorn, Joel Dunning, et al.
Oncogene|December 17, 2025
MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumorsHülya Dogan, Martin Liptay, Joana S Barbosa, et al.
British Journal of Cancer|May 14, 2009
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonismB Cambien, B F Karimdjee, P Richard-Fiardo, et al.
Pageof 102